A phase I trial of SR271425 given as a one hour infusion every 3 weeks to patients with advanced solid tumors
Wadler S, Loh E, Pilat M, Malburg L, Holloway S, Matthews N, Shackleton G, Valdivieso M, Lorusso P. A phase I trial of SR271425 given as a one hour infusion every 3 weeks to patients with advanced solid tumors. Journal Of Clinical Oncology 2005, 23: 2030-2030. DOI: 10.1200/jco.2005.23.16_suppl.2030.Peer-Reviewed Original Research